Finance

Lists
NAUT:NASDAQ
Nautilus Biotechnology Inc
၁.၉၆ US$
၀.၀၀%
(၀.၀၀) 1D
၂.၁၆ US$
+၁၀.၂၈% (+၀.၂၀)
Pre-market
Closed: အောက် ၂, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAUT...
Mkt. cap
၂၄.၉၄ ကုဋေ
Avg. vol.
၂.၈၆ သန်း
Volume
၁.၆၄ သန်း
52-wk high
၄.၃၁ US$
52-wk low
၀.၈၂ US$
EPS
-၀.၄၅ US$
Beta
၀.၇၃
Shares outstanding
၁၂.၇၃ ကုဋေ
No. of employees
၁၂၇
Mkt. cap
၂၄.၉၄ ကုဋေ
Avg. vol.
၂.၈၆ သန်း
Volume
၁.၆၄ သန်း
52-wk high
၄.၃၁ US$
52-wk low
၀.၈၂ US$
EPS
-၀.၄၅ US$
Beta
၀.၇၃
Shares outstanding
၁၂.၇၃ ကုဋေ
No. of employees
၁၂၇
News stories
From web sources and news partners
Business Wire
Business Wire
·
ပြီးခဲ့သည့် ၃၄ မိနစ်
Powerus (Nasdaq: PUSA) Awarded $82 Million Order for Counter-Unmanned Aerial Systems
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၆ မိနစ်
Should Engine Ignition Test Require Action From Kratos (KTOS) Investors?
GlobeNewswire
GlobeNewswire
·
ပြီးခဲ့သည့် ၂၄ မိနစ်
DEEP FISSION, INC. (NASDAQ: FISN) INVESTIGATION: Johnson
About Nautilus Biotechnology Inc
CEO-
Employees၁၂၇
Founded၂၀၁၆
Headquartersဆီအက်တယ်, ဝါရှင်တန်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to NAUT in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NAUT in the last 3 months.
Highest
Current ၁.၉၆ US$
၄.၀၀ US$ (+၁၀၄.၀၈%)
Average
၃.၈၃ US$ (+၉၅.၄၁%)
Lowest
၃.၅၀ US$ (+၇၈.၅၇%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Buy
Initiated
၃.၅၀ US$
+၇၈.၆%
09/29/2026
Unknown Analyst
Leerink Partners
Buy
Initiated
၄.၀၀ US$
+၁၀၄.၁%
09/09/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
၄.၀၀ US$
+၁၀၄.၁%
07/28/2026
Daniel Brennan
TD Cowen
Buy
Maintained
-
-
04/28/2026
Last report
၂၀၂၆ ဇူ ၂၈
Fiscal period
Q2 2026
EPS / Est. (USD)
-၀.၁၁ US$ / -၀.၁၄ US$
+၂၁.၄၃%beat
Revenue / Est. (USD)
၁.၉၀ သိန်း / ၀.၀၀
၀.၀၀%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
၁.၉၀ သိန်း
Cost of goods sold
-
-
-
၁.၅၀ သောင်း
Cost of revenue
-
-
-
၁.၅၀ သောင်း
Research and development expenses
၉.၆၀ သန်း
၉.၅၈ သန်း
၉.၇၁ သန်း
၉.၆၁ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅.၈၇ သန်း
၅.၈၅ သန်း
၆.၄၂ သန်း
၆.၃၂ သန်း
Operating expense
၁.၅၅ ကုဋေ
၁.၅၄ ကုဋေ
၁.၆၁ ကုဋေ
၁.၅၉ ကုဋေ
Total operating expenses
၁.၅၅ ကုဋေ
၁.၅၄ ကုဋေ
၁.၆၁ ကုဋေ
၁.၆၀ ကုဋေ
Operating income
-၁.၅၅ ကုဋေ
-၁.၅၄ ကုဋေ
-၁.၆၁ ကုဋေ
-၁.၅၈ ကုဋေ
Other non operating income
-၅.၀၀ ထောင်
-၁.၄၅ သိန်း
-၁.၅၀ သောင်း
-၁.၃၀ သောင်း
EBT including unusual items
-၁.၃၆ ကုဋေ
-၁.၃၈ ကုဋေ
-၁.၄၇ ကုဋေ
-၁.၄၅ ကုဋေ
EBT excluding unusual items
-၁.၃၆ ကုဋေ
-၁.၃၉ ကုဋေ
-၁.၄၇ ကုဋေ
-၁.၄၅ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၃၆ ကုဋေ
-၁.၃၈ ကုဋေ
-၁.၄၇ ကုဋေ
-၁.၄၅ ကုဋေ
Net profit margin
-
-
-
-၇,၆၁၅.၂၆%
Earnings per share
-
-
-
-
Interest and investment income
၁.၉၀ သန်း
၁.၆၅ သန်း
၁.၄၄ သန်း
၁.၃၁ သန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၉၀ သန်း
၁.၆၅ သန်း
၁.၄၄ သန်း
၁.၃၁ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၅၀ ကုဋေ
-၁.၅၀ ကုဋေ
-၁.၅၈ ကုဋေ
-၁.၅၅ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ